[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Intranasal Drug Delivery Devices Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

April 2024 | 126 pages | ID: G59F8B1BF8BEEN
APO Research

US$ 3,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. Intranasal Drug Delivery Devices are medical devices used for drug delivery through noses.

According to APO Research, The global Intranasal Drug Delivery Devices market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

North America is the largest region of Intranasal Drug Delivery Devices, with a market share about 40%. It was followed by Europe with 35%. BD, AptarGroup, 3M Company, Teleflex, H&T Presspart and Bespak are the top 6 manufacturers of industry, and they had about 85% combined market share.

This report presents an overview of global market for Intranasal Drug Delivery Devices, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Intranasal Drug Delivery Devices, also provides the sales of main regions and countries. Of the upcoming market potential for Intranasal Drug Delivery Devices, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Intranasal Drug Delivery Devices sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Intranasal Drug Delivery Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Intranasal Drug Delivery Devices sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including BD, AptarGroup, 3M, Teleflex, H?T Presspart and Bespak, etc.

Intranasal Drug Delivery Devices segment by Company
  • BD
  • AptarGroup
  • 3M
  • Teleflex
  • H?T Presspart
  • Bespak
Intranasal Drug Delivery Devices segment by Type
  • Multidose
  • Uni/bidose
Intranasal Drug Delivery Devices segment by Application
  • Personal Use
  • Hospital Use
Intranasal Drug Delivery Devices segment by Region
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • China Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intranasal Drug Delivery Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intranasal Drug Delivery Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intranasal Drug Delivery Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Intranasal Drug Delivery Devices market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Intranasal Drug Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Intranasal Drug Delivery Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Intranasal Drug Delivery Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report
1 MARKET OVERVIEW

1.1 Product Definition
1.2 Global Intranasal Drug Delivery Devices Market Size, 2019 VS 2023 VS 2030
1.3 Global Intranasal Drug Delivery Devices Market Size Estimates and Forecasts (2019-2030)
1.4 Global Intranasal Drug Delivery Devices Sales Estimates and Forecasts (2019-2030)
1.5 Global Intranasal Drug Delivery Devices Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives

2 GLOBAL INTRANASAL DRUG DELIVERY DEVICES MARKET DYNAMICS

2.1 Intranasal Drug Delivery Devices Industry Trends
2.2 Intranasal Drug Delivery Devices Industry Drivers
2.3 Intranasal Drug Delivery Devices Industry Opportunities and Challenges
2.4 Intranasal Drug Delivery Devices Industry Restraints

3 INTRANASAL DRUG DELIVERY DEVICES MARKET BY MANUFACTURERS

3.1 Global Intranasal Drug Delivery Devices Revenue by Manufacturers (2019-2024)
3.2 Global Intranasal Drug Delivery Devices Sales by Manufacturers (2019-2024)
3.3 Global Intranasal Drug Delivery Devices Average Sales Price by Manufacturers (2019-2024)
3.4 Global Intranasal Drug Delivery Devices Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Intranasal Drug Delivery Devices Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Intranasal Drug Delivery Devices Manufacturers, Product Type & Application
3.7 Global Intranasal Drug Delivery Devices Manufacturers Commercialization Time
3.8 Market Competitive Analysis
  3.8.1 Global Intranasal Drug Delivery Devices Market CR5 and HHI
  3.8.2 Global Top 5 and 10 Intranasal Drug Delivery Devices Players Market Share by Revenue in 2023
  3.8.3 2023 Intranasal Drug Delivery Devices Tier 1, Tier 2, and Tier

4 INTRANASAL DRUG DELIVERY DEVICES MARKET BY TYPE

4.1 Intranasal Drug Delivery Devices Type Introduction
  4.1.1 Multidose
  4.1.2 Uni/bidose
4.2 Global Intranasal Drug Delivery Devices Sales by Type
  4.2.1 Global Intranasal Drug Delivery Devices Sales by Type (2019 VS 2023 VS 2030)
  4.2.2 Global Intranasal Drug Delivery Devices Sales by Type (2019-2030)
  4.2.3 Global Intranasal Drug Delivery Devices Sales Market Share by Type (2019-2030)
4.3 Global Intranasal Drug Delivery Devices Revenue by Type
  4.3.1 Global Intranasal Drug Delivery Devices Revenue by Type (2019 VS 2023 VS 2030)
  4.3.2 Global Intranasal Drug Delivery Devices Revenue by Type (2019-2030)
  4.3.3 Global Intranasal Drug Delivery Devices Revenue Market Share by Type (2019-2030)

5 INTRANASAL DRUG DELIVERY DEVICES MARKET BY APPLICATION

5.1 Intranasal Drug Delivery Devices Application Introduction
  5.1.1 Personal Use
  5.1.2 Hospital Use
5.2 Global Intranasal Drug Delivery Devices Sales by Application
  5.2.1 Global Intranasal Drug Delivery Devices Sales by Application (2019 VS 2023 VS 2030)
  5.2.2 Global Intranasal Drug Delivery Devices Sales by Application (2019-2030)
  5.2.3 Global Intranasal Drug Delivery Devices Sales Market Share by Application (2019-2030)
5.3 Global Intranasal Drug Delivery Devices Revenue by Application
  5.3.1 Global Intranasal Drug Delivery Devices Revenue by Application (2019 VS 2023 VS 2030)
  5.3.2 Global Intranasal Drug Delivery Devices Revenue by Application (2019-2030)
  5.3.3 Global Intranasal Drug Delivery Devices Revenue Market Share by Application (2019-2030)

6 GLOBAL INTRANASAL DRUG DELIVERY DEVICES SALES BY REGION

6.1 Global Intranasal Drug Delivery Devices Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Intranasal Drug Delivery Devices Sales by Region (2019-2030)
  6.2.1 Global Intranasal Drug Delivery Devices Sales by Region (2019-2024)
  6.2.2 Global Intranasal Drug Delivery Devices Sales Forecasted by Region (2025-2030)
6.3 North America
  6.3.1 North America Intranasal Drug Delivery Devices Sales Growth Rate by Country: 2019 VS 2023 VS 2030
  6.3.2 North America Intranasal Drug Delivery Devices Sales by Country (2019-2030)
  6.3.3 U.S.
  6.3.4 Canada
6.4 Europe
  6.4.1 Europe Intranasal Drug Delivery Devices Sales Growth Rate by Country: 2019 VS 2023 VS 2030
  6.4.2 Europe Intranasal Drug Delivery Devices Sales by Country (2019-2030)
  6.4.3 Germany
  6.4.4 France
  6.4.5 U.K.
  6.4.6 Italy
  6.4.7 Netherlands
6.5 Asia Pacific
  6.5.1 Asia Pacific Intranasal Drug Delivery Devices Sales Growth Rate by Country: 2019 VS 2023 VS 2030
  6.5.2 Asia Pacific Intranasal Drug Delivery Devices Sales by Country (2019-2030)
  6.5.3 China
  6.5.4 Japan
  6.5.5 South Korea
  6.5.6 Southeast Asia
  6.5.7 India
  6.5.8 Australia
6.6 LAMEA
  6.6.1 LAMEA Intranasal Drug Delivery Devices Sales Growth Rate by Country: 2019 VS 2023 VS 2030
  6.6.2 LAMEA Intranasal Drug Delivery Devices Sales by Country (2019-2030)
  6.6.3 Mexico
  6.6.4 Brazil
  6.6.5 Turkey
  6.6.6 GCC Countries

7 GLOBAL INTRANASAL DRUG DELIVERY DEVICES REVENUE BY REGION

7.1 Global Intranasal Drug Delivery Devices Revenue by Region
  7.1.1 Global Intranasal Drug Delivery Devices Revenue by Region: 2019 VS 2023 VS 2030
  7.1.2 Global Intranasal Drug Delivery Devices Revenue by Region (2019-2024)
  7.1.3 Global Intranasal Drug Delivery Devices Revenue by Region (2025-2030)
  7.1.4 Global Intranasal Drug Delivery Devices Revenue Market Share by Region (2019-2030)
7.2 North America
  7.2.1 North America Intranasal Drug Delivery Devices Revenue (2019-2030)
  7.2.2 North America Intranasal Drug Delivery Devices Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
  7.3.1 Europe Intranasal Drug Delivery Devices Revenue (2019-2030)
  7.3.2 Europe Intranasal Drug Delivery Devices Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
  7.4.1 Asia-Pacific Intranasal Drug Delivery Devices Revenue (2019-2030)
  7.4.2 Asia-Pacific Intranasal Drug Delivery Devices Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
  7.5.1 LAMEA Intranasal Drug Delivery Devices Revenue (2019-2030)
  7.5.2 LAMEA Intranasal Drug Delivery Devices Revenue Share by Country: 2019 VS 2023 VS 2030

8 COMPANY PROFILES

8.1 BD
  8.1.1 BD Comapny Information
  8.1.2 BD Business Overview
  8.1.3 BD Intranasal Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2024)
  8.1.4 BD Intranasal Drug Delivery Devices Product Portfolio
  8.1.5 BD Recent Developments
8.2 AptarGroup
  8.2.1 AptarGroup Comapny Information
  8.2.2 AptarGroup Business Overview
  8.2.3 AptarGroup Intranasal Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2024)
  8.2.4 AptarGroup Intranasal Drug Delivery Devices Product Portfolio
  8.2.5 AptarGroup Recent Developments
8.3 3M
  8.3.1 3M Comapny Information
  8.3.2 3M Business Overview
  8.3.3 3M Intranasal Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2024)
  8.3.4 3M Intranasal Drug Delivery Devices Product Portfolio
  8.3.5 3M Recent Developments
8.4 Teleflex
  8.4.1 Teleflex Comapny Information
  8.4.2 Teleflex Business Overview
  8.4.3 Teleflex Intranasal Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2024)
  8.4.4 Teleflex Intranasal Drug Delivery Devices Product Portfolio
  8.4.5 Teleflex Recent Developments
8.5 H?T Presspart
  8.5.1 H?T Presspart Comapny Information
  8.5.2 H?T Presspart Business Overview
  8.5.3 H?T Presspart Intranasal Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2024)
  8.5.4 H?T Presspart Intranasal Drug Delivery Devices Product Portfolio
  8.5.5 H?T Presspart Recent Developments
8.6 Bespak
  8.6.1 Bespak Comapny Information
  8.6.2 Bespak Business Overview
  8.6.3 Bespak Intranasal Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2024)
  8.6.4 Bespak Intranasal Drug Delivery Devices Product Portfolio
  8.6.5 Bespak Recent Developments

9 VALUE CHAIN AND SALES CHANNELS ANALYSIS

9.1 Intranasal Drug Delivery Devices Value Chain Analysis
  9.1.1 Intranasal Drug Delivery Devices Key Raw Materials
  9.1.2 Raw Materials Key Suppliers
  9.1.3 Manufacturing Cost Structure
  9.1.4 Intranasal Drug Delivery Devices Production Mode & Process
9.2 Intranasal Drug Delivery Devices Sales Channels Analysis
  9.2.1 Direct Comparison with Distribution Share
  9.2.2 Intranasal Drug Delivery Devices Distributors
  9.2.3 Intranasal Drug Delivery Devices Customers

10 CONCLUDING INSIGHTS

11 APPENDIX

11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
  11.5.1 Secondary Sources
  11.5.2 Primary Sources
11.6 Disclaimer


More Publications